Literature DB >> 1602379

Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase.

H Safayhi1, T Mack, J Sabieraj, M I Anazodo, L R Subramanian, H P Ammon.   

Abstract

Isomers (alpha- and beta-) of boswellic acids (BAs), 11-keto-beta-BA and their acetyl derivatives were isolated from the gum resin of Boswellia serrata. BA and derivatives concentration dependently decreased the formation of leukotriene B4 from endogenous arachidonic acid in rat peritoneal neutrophils. Among the BAs, acetyl-11-keto-beta-BA induced the most pronounced inhibition of 5-lipoxygenase (5-LO) product formation with an IC50 of 1.5 microM. In contrast to the redox type 5-LO inhibitor nordihydroguaiaretic acid, BA in concentrations up to 400 microM did not impair the cyclooxygenase and 12-lipoxygenase in isolated human platelets and the peroxidation of arachidonic acid by Fe-ascorbate. The data strongly suggest that BAs are specific, nonreducing-type inhibitors of the 5-LO product formation either interacting directly with the 5-LO or blocking its translocation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1602379

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  61 in total

1.  Effect of Boswellia serrata on intestinal motility in rodents: inhibition of diarrhoea without constipation.

Authors:  Francesca Borrelli; Francesco Capasso; Raffaele Capasso; Valeria Ascione; Gabriella Aviello; Rocco Longo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

2.  Triterpenoid resinous metabolites from the genus Boswellia: pharmacological activities and potential species-identifying properties.

Authors:  Yuxin Zhang; Zhangchi Ning; Cheng Lu; Siyu Zhao; Jianfen Wang; Baoqin Liu; Xuegong Xu; Yuanyan Liu
Journal:  Chem Cent J       Date:  2013-09-12       Impact factor: 4.215

3.  SZB120 Exhibits Immunomodulatory Effects by Targeting eIF2α to Suppress Th17 Cell Differentiation.

Authors:  Linjiao Chen; Jing Bai; Danhong Peng; Yuanyuan Gao; Xiaojie Cai; Junxun Zhang; Sibei Tang; Liman Niu; Yang Sun; Fangzhou Lou; Hong Zhou; Qianqian Yin; Zhikai Wang; Libo Sun; Xuemei Du; Zhenyao Xu; Hong Wang; Qun Li; Honglin Wang
Journal:  J Immunol       Date:  2021-01-22       Impact factor: 5.422

4.  Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.

Authors:  Xiufeng Pang; Zhengfang Yi; Xiaoli Zhang; Bokyung Sung; Weijing Qu; Xiaoyuan Lian; Bharat B Aggarwal; Mingyao Liu
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

5.  Evaluation of systemic administration of Boswellia papyrifera extracts on spatial memory retention in male rats.

Authors:  Ali Mahmoudi; Ali Hosseini-Sharifabad; Hamid R Monsef-Esfahani; Ali R Yazdinejad; Mahnaz Khanavi; Ali Roghani; Cordian Beyer; Mohammad Sharifzadeh
Journal:  J Nat Med       Date:  2011-04-11       Impact factor: 2.343

6.  Induction of central signalling pathways and select functional effects in human platelets by beta-boswellic acid.

Authors:  Daniel Poeckel; Lars Tausch; Anja Altmann; Christian Feisst; Ute Klinkhardt; Jochen Graff; Sebastian Harder; Oliver Werz
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

7.  Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial.

Authors:  Ahmed Madisch; Stephan Miehlke; Otto Eichele; Jenny Mrwa; Birgit Bethke; Eberhard Kuhlisch; Elke Bästlein; Georg Wilhelms; Andrea Morgner; Bernd Wigginghaus; Manfred Stolte
Journal:  Int J Colorectal Dis       Date:  2007-09-02       Impact factor: 2.571

8.  Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1.

Authors:  Ajaikumar B Kunnumakkara; Asha S Nair; Bokyung Sung; Manoj K Pandey; Bharat B Aggarwal
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

9.  Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity.

Authors:  E R Sailer; L R Subramanian; B Rall; R F Hoernlein; H P Ammon; H Safayhi
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

10.  Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.

Authors:  Krishanu Sengupta; Alluri V Krishnaraju; Amar A Vishal; Artatrana Mishra; Golakoti Trimurtulu; Kadainti V S Sarma; Smriti K Raychaudhuri; Siba P Raychaudhuri
Journal:  Int J Med Sci       Date:  2010-11-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.